Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial

BACKGROUND: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure. Although angiotensin II receptor blockers (ARBs) can be used to attenuate proteinuria in DN patients, their efficacy remains limited. This clinical trial aimed to evaluate the efficacy of Tripterygium wilfordi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ge, Yongchun, Xie, Honglang, Li, Shijun, Jin, Bo, Hou, Jinhua, Zhang, Haitao, Shi, Mingjun, Liu, Zhihong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3670993/
https://ncbi.nlm.nih.gov/pubmed/23725518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-134
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados